Global Antisense Oligonucleotides (ASOs) Drugs Market Growth 2026-2032
The global Antisense Oligonucleotides (ASOs) Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).
United States market for Antisense Oligonucleotides (ASOs) Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Antisense Oligonucleotides (ASOs) Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Antisense Oligonucleotides (ASOs) Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Antisense Oligonucleotides (ASOs) Drugs players cover Lonis Pharmaceuticals, Novartis, Sanofi, GSK, Sarepta, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Antisense Oligonucleotides (ASOs) Drugs Industry Forecast? looks at past sales and reviews total world Antisense Oligonucleotides (ASOs) Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Antisense Oligonucleotides (ASOs) Drugs sales for 2026 through 2032. With Antisense Oligonucleotides (ASOs) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antisense Oligonucleotides (ASOs) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Antisense Oligonucleotides (ASOs) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antisense Oligonucleotides (ASOs) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antisense Oligonucleotides (ASOs) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antisense Oligonucleotides (ASOs) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antisense Oligonucleotides (ASOs) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Antisense Oligonucleotides (ASOs) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Drugs--Antisense oligonucleotides (ASO, Antisense oligonucleotides) are chemically modified single-stranded DNA or RNA molecule fragments, usually 15-30 nucleotides in length, that interact with endogenous molecules through Watson-Crick base pairing rules. Specific binding to sexual mRNA targets. ASO includes antisense RNA (asRNA) and antisense DNA (asDNA).
United States market for Antisense Oligonucleotides (ASOs) Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Antisense Oligonucleotides (ASOs) Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Antisense Oligonucleotides (ASOs) Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Antisense Oligonucleotides (ASOs) Drugs players cover Lonis Pharmaceuticals, Novartis, Sanofi, GSK, Sarepta, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Antisense Oligonucleotides (ASOs) Drugs Industry Forecast? looks at past sales and reviews total world Antisense Oligonucleotides (ASOs) Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Antisense Oligonucleotides (ASOs) Drugs sales for 2026 through 2032. With Antisense Oligonucleotides (ASOs) Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antisense Oligonucleotides (ASOs) Drugs industry.
This Insight Report provides a comprehensive analysis of the global Antisense Oligonucleotides (ASOs) Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antisense Oligonucleotides (ASOs) Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Antisense Oligonucleotides (ASOs) Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antisense Oligonucleotides (ASOs) Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antisense Oligonucleotides (ASOs) Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Antisense Oligonucleotides (ASOs) Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Cleave and Degrade
- Splice
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonis Pharmaceuticals
- Novartis
- Sanofi
- GSK
- Sarepta
- Kastle
- Biogen
- What is the 10-year outlook for the global Antisense Oligonucleotides (ASOs) Drugs market?
- What factors are driving Antisense Oligonucleotides (ASOs) Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Antisense Oligonucleotides (ASOs) Drugs market opportunities vary by end market size?
- How does Antisense Oligonucleotides (ASOs) Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Antisense Oligonucleotides (ASOs) Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Antisense Oligonucleotides (ASOs) Drugs by Country/Region, 2021, 2025 & 2032
2.2 Antisense Oligonucleotides (ASOs) Drugs Segment by Type
2.2.1 Cleave and Degrade
2.2.2 Splice
2.2.3 Antisense Oligonucleotides (ASOs) Drugs Sales by Type
2.2.3.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Type (2021-2026)
2.3 Antisense Oligonucleotides (ASOs) Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Antisense Oligonucleotides (ASOs) Drugs Sales by Application
2.3.3.1 Global Antisense Oligonucleotides (ASOs) Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Antisense Oligonucleotides (ASOs) Drugs Breakdown Data by Company
3.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Company (2021-2026)
3.2 Global Antisense Oligonucleotides (ASOs) Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Company (2021-2026)
3.2.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Company
3.4 Key Manufacturers Antisense Oligonucleotides (ASOs) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antisense Oligonucleotides (ASOs) Drugs Product Location Distribution
3.4.2 Players Antisense Oligonucleotides (ASOs) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTISENSE OLIGONUCLEOTIDES (ASOS) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Antisense Oligonucleotides (ASOs) Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Antisense Oligonucleotides (ASOs) Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Antisense Oligonucleotides (ASOs) Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Antisense Oligonucleotides (ASOs) Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antisense Oligonucleotides (ASOs) Drugs Sales Growth
4.4 APAC Antisense Oligonucleotides (ASOs) Drugs Sales Growth
4.5 Europe Antisense Oligonucleotides (ASOs) Drugs Sales Growth
4.6 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Growth
5 AMERICAS
5.1 Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Country
5.1.1 Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026)
5.1.2 Americas Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026)
5.2 Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026)
5.3 Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Region
6.1.1 APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2021-2026)
6.1.2 APAC Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2021-2026)
6.2 APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026)
6.3 APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antisense Oligonucleotides (ASOs) Drugs by Country
7.1.1 Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026)
7.1.2 Europe Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026)
7.2 Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026)
7.3 Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs by Country
8.1.1 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antisense Oligonucleotides (ASOs) Drugs
10.3 Manufacturing Process Analysis of Antisense Oligonucleotides (ASOs) Drugs
10.4 Industry Chain Structure of Antisense Oligonucleotides (ASOs) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antisense Oligonucleotides (ASOs) Drugs Distributors
11.3 Antisense Oligonucleotides (ASOs) Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTISENSE OLIGONUCLEOTIDES (ASOS) DRUGS BY GEOGRAPHIC REGION
12.1 Global Antisense Oligonucleotides (ASOs) Drugs Market Size Forecast by Region
12.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Forecast by Region (2027-2032)
12.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Antisense Oligonucleotides (ASOs) Drugs Forecast by Type (2027-2032)
12.7 Global Antisense Oligonucleotides (ASOs) Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lonis Pharmaceuticals
13.1.1 Lonis Pharmaceuticals Company Information
13.1.2 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.1.3 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lonis Pharmaceuticals Main Business Overview
13.1.5 Lonis Pharmaceuticals Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.2.3 Novartis Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.3.3 Sanofi Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.4.3 GSK Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sarepta
13.5.1 Sarepta Company Information
13.5.2 Sarepta Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.5.3 Sarepta Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sarepta Main Business Overview
13.5.5 Sarepta Latest Developments
13.6 Kastle
13.6.1 Kastle Company Information
13.6.2 Kastle Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.6.3 Kastle Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kastle Main Business Overview
13.6.5 Kastle Latest Developments
13.7 Biogen
13.7.1 Biogen Company Information
13.7.2 Biogen Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.7.3 Biogen Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biogen Main Business Overview
13.7.5 Biogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Antisense Oligonucleotides (ASOs) Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Antisense Oligonucleotides (ASOs) Drugs by Country/Region, 2021, 2025 & 2032
2.2 Antisense Oligonucleotides (ASOs) Drugs Segment by Type
2.2.1 Cleave and Degrade
2.2.2 Splice
2.2.3 Antisense Oligonucleotides (ASOs) Drugs Sales by Type
2.2.3.1 Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Type (2021-2026)
2.3 Antisense Oligonucleotides (ASOs) Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Antisense Oligonucleotides (ASOs) Drugs Sales by Application
2.3.3.1 Global Antisense Oligonucleotides (ASOs) Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Antisense Oligonucleotides (ASOs) Drugs Breakdown Data by Company
3.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Company (2021-2026)
3.2 Global Antisense Oligonucleotides (ASOs) Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Company (2021-2026)
3.2.2 Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Company
3.4 Key Manufacturers Antisense Oligonucleotides (ASOs) Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antisense Oligonucleotides (ASOs) Drugs Product Location Distribution
3.4.2 Players Antisense Oligonucleotides (ASOs) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTISENSE OLIGONUCLEOTIDES (ASOS) DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Antisense Oligonucleotides (ASOs) Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Antisense Oligonucleotides (ASOs) Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Antisense Oligonucleotides (ASOs) Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Antisense Oligonucleotides (ASOs) Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Antisense Oligonucleotides (ASOs) Drugs Sales Growth
4.4 APAC Antisense Oligonucleotides (ASOs) Drugs Sales Growth
4.5 Europe Antisense Oligonucleotides (ASOs) Drugs Sales Growth
4.6 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Growth
5 AMERICAS
5.1 Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Country
5.1.1 Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026)
5.1.2 Americas Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026)
5.2 Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026)
5.3 Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Region
6.1.1 APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2021-2026)
6.1.2 APAC Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2021-2026)
6.2 APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026)
6.3 APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antisense Oligonucleotides (ASOs) Drugs by Country
7.1.1 Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026)
7.1.2 Europe Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026)
7.2 Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026)
7.3 Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs by Country
8.1.1 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antisense Oligonucleotides (ASOs) Drugs
10.3 Manufacturing Process Analysis of Antisense Oligonucleotides (ASOs) Drugs
10.4 Industry Chain Structure of Antisense Oligonucleotides (ASOs) Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antisense Oligonucleotides (ASOs) Drugs Distributors
11.3 Antisense Oligonucleotides (ASOs) Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTISENSE OLIGONUCLEOTIDES (ASOS) DRUGS BY GEOGRAPHIC REGION
12.1 Global Antisense Oligonucleotides (ASOs) Drugs Market Size Forecast by Region
12.1.1 Global Antisense Oligonucleotides (ASOs) Drugs Forecast by Region (2027-2032)
12.1.2 Global Antisense Oligonucleotides (ASOs) Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Antisense Oligonucleotides (ASOs) Drugs Forecast by Type (2027-2032)
12.7 Global Antisense Oligonucleotides (ASOs) Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Lonis Pharmaceuticals
13.1.1 Lonis Pharmaceuticals Company Information
13.1.2 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.1.3 Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Lonis Pharmaceuticals Main Business Overview
13.1.5 Lonis Pharmaceuticals Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.2.3 Novartis Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.3.3 Sanofi Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.4.3 GSK Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Sarepta
13.5.1 Sarepta Company Information
13.5.2 Sarepta Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.5.3 Sarepta Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sarepta Main Business Overview
13.5.5 Sarepta Latest Developments
13.6 Kastle
13.6.1 Kastle Company Information
13.6.2 Kastle Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.6.3 Kastle Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Kastle Main Business Overview
13.6.5 Kastle Latest Developments
13.7 Biogen
13.7.1 Biogen Company Information
13.7.2 Biogen Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
13.7.3 Biogen Antisense Oligonucleotides (ASOs) Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Biogen Main Business Overview
13.7.5 Biogen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antisense Oligonucleotides (ASOs) Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Antisense Oligonucleotides (ASOs) Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cleave and Degrade
Table 4. Major Players of Splice
Table 5. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Antisense Oligonucleotides (ASOs) Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Antisense Oligonucleotides (ASOs) Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Antisense Oligonucleotides (ASOs) Drugs Producing Area Distribution and Sales Area
Table 21. Players Antisense Oligonucleotides (ASOs) Drugs Products Offered
Table 22. Antisense Oligonucleotides (ASOs) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Antisense Oligonucleotides (ASOs) Drugs
Table 52. Key Market Challenges & Risks of Antisense Oligonucleotides (ASOs) Drugs
Table 53. Key Industry Trends of Antisense Oligonucleotides (ASOs) Drugs
Table 54. Antisense Oligonucleotides (ASOs) Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Antisense Oligonucleotides (ASOs) Drugs Distributors List
Table 57. Antisense Oligonucleotides (ASOs) Drugs Customer List
Table 58. Global Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Antisense Oligonucleotides (ASOs) Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Antisense Oligonucleotides (ASOs) Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Lonis Pharmaceuticals Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 74. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Lonis Pharmaceuticals Main Business
Table 76. Lonis Pharmaceuticals Latest Developments
Table 77. Novartis Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 79. Novartis Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Sanofi Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 84. Sanofi Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. GSK Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 89. GSK Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Sarepta Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Sarepta Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 94. Sarepta Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sarepta Main Business
Table 96. Sarepta Latest Developments
Table 97. Kastle Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Kastle Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 99. Kastle Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Kastle Main Business
Table 101. Kastle Latest Developments
Table 102. Biogen Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Biogen Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 104. Biogen Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Biogen Main Business
Table 106. Biogen Latest Developments
Table 1. Antisense Oligonucleotides (ASOs) Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Antisense Oligonucleotides (ASOs) Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cleave and Degrade
Table 4. Major Players of Splice
Table 5. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Table 7. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Antisense Oligonucleotides (ASOs) Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global Antisense Oligonucleotides (ASOs) Drugs Sale Market Share by Application (2021-2026)
Table 12. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Company (2021-2026)
Table 17. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global Antisense Oligonucleotides (ASOs) Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Antisense Oligonucleotides (ASOs) Drugs Producing Area Distribution and Sales Area
Table 21. Players Antisense Oligonucleotides (ASOs) Drugs Products Offered
Table 22. Antisense Oligonucleotides (ASOs) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Antisense Oligonucleotides (ASOs) Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global Antisense Oligonucleotides (ASOs) Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC Antisense Oligonucleotides (ASOs) Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Antisense Oligonucleotides (ASOs) Drugs
Table 52. Key Market Challenges & Risks of Antisense Oligonucleotides (ASOs) Drugs
Table 53. Key Industry Trends of Antisense Oligonucleotides (ASOs) Drugs
Table 54. Antisense Oligonucleotides (ASOs) Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Antisense Oligonucleotides (ASOs) Drugs Distributors List
Table 57. Antisense Oligonucleotides (ASOs) Drugs Customer List
Table 58. Global Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Antisense Oligonucleotides (ASOs) Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Antisense Oligonucleotides (ASOs) Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Antisense Oligonucleotides (ASOs) Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Lonis Pharmaceuticals Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 74. Lonis Pharmaceuticals Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Lonis Pharmaceuticals Main Business
Table 76. Lonis Pharmaceuticals Latest Developments
Table 77. Novartis Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 79. Novartis Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. Sanofi Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 84. Sanofi Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. GSK Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. GSK Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 89. GSK Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. GSK Main Business
Table 91. GSK Latest Developments
Table 92. Sarepta Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Sarepta Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 94. Sarepta Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sarepta Main Business
Table 96. Sarepta Latest Developments
Table 97. Kastle Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Kastle Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 99. Kastle Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Kastle Main Business
Table 101. Kastle Latest Developments
Table 102. Biogen Basic Information, Antisense Oligonucleotides (ASOs) Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Biogen Antisense Oligonucleotides (ASOs) Drugs Product Portfolios and Specifications
Table 104. Biogen Antisense Oligonucleotides (ASOs) Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Biogen Main Business
Table 106. Biogen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antisense Oligonucleotides (ASOs) Drugs
Figure 2. Antisense Oligonucleotides (ASOs) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antisense Oligonucleotides (ASOs) Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Antisense Oligonucleotides (ASOs) Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country/Region (2025)
Figure 10. Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cleave and Degrade
Figure 12. Product Picture of Splice
Figure 13. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type in 2026
Figure 14. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Antisense Oligonucleotides (ASOs) Drugs Consumed in Hospital
Figure 16. Global Antisense Oligonucleotides (ASOs) Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. Antisense Oligonucleotides (ASOs) Drugs Consumed in Clinic
Figure 18. Global Antisense Oligonucleotides (ASOs) Drugs Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Antisense Oligonucleotides (ASOs) Drugs Sale Market Share by Application (2025)
Figure 20. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application in 2026
Figure 21. Antisense Oligonucleotides (ASOs) Drugs Sales by Company in 2026 (K Units)
Figure 22. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Company in 2026
Figure 23. Antisense Oligonucleotides (ASOs) Drugs Revenue by Company in 2026 ($ millions)
Figure 24. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Company in 2026
Figure 25. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Antisense Oligonucleotides (ASOs) Drugs Sales 2021-2026 (K Units)
Figure 28. Americas Antisense Oligonucleotides (ASOs) Drugs Revenue 2021-2026 ($ millions)
Figure 29. APAC Antisense Oligonucleotides (ASOs) Drugs Sales 2021-2026 (K Units)
Figure 30. APAC Antisense Oligonucleotides (ASOs) Drugs Revenue 2021-2026 ($ millions)
Figure 31. Europe Antisense Oligonucleotides (ASOs) Drugs Sales 2021-2026 (K Units)
Figure 32. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Revenue 2021-2026 ($ millions)
Figure 35. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country in 2026
Figure 36. Americas Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2021-2026)
Figure 37. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Figure 38. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2021-2026)
Figure 39. United States Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Region in 2026
Figure 44. APAC Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Region (2021-2026)
Figure 45. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Figure 46. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2021-2026)
Figure 47. China Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. India Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country in 2026
Figure 55. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2021-2026)
Figure 56. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Figure 57. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2021-2026)
Figure 58. Germany Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. France Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2021-2026)
Figure 66. Egypt Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Antisense Oligonucleotides (ASOs) Drugs in 2026
Figure 72. Manufacturing Process Analysis of Antisense Oligonucleotides (ASOs) Drugs
Figure 73. Industry Chain Structure of Antisense Oligonucleotides (ASOs) Drugs
Figure 74. Channels of Distribution
Figure 75. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Forecast by Region (2027-2032)
Figure 76. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Antisense Oligonucleotides (ASOs) Drugs
Figure 2. Antisense Oligonucleotides (ASOs) Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antisense Oligonucleotides (ASOs) Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Antisense Oligonucleotides (ASOs) Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country/Region (2025)
Figure 10. Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Cleave and Degrade
Figure 12. Product Picture of Splice
Figure 13. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type in 2026
Figure 14. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Type (2021-2026)
Figure 15. Antisense Oligonucleotides (ASOs) Drugs Consumed in Hospital
Figure 16. Global Antisense Oligonucleotides (ASOs) Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. Antisense Oligonucleotides (ASOs) Drugs Consumed in Clinic
Figure 18. Global Antisense Oligonucleotides (ASOs) Drugs Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Antisense Oligonucleotides (ASOs) Drugs Sale Market Share by Application (2025)
Figure 20. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Application in 2026
Figure 21. Antisense Oligonucleotides (ASOs) Drugs Sales by Company in 2026 (K Units)
Figure 22. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Company in 2026
Figure 23. Antisense Oligonucleotides (ASOs) Drugs Revenue by Company in 2026 ($ millions)
Figure 24. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Company in 2026
Figure 25. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Antisense Oligonucleotides (ASOs) Drugs Sales 2021-2026 (K Units)
Figure 28. Americas Antisense Oligonucleotides (ASOs) Drugs Revenue 2021-2026 ($ millions)
Figure 29. APAC Antisense Oligonucleotides (ASOs) Drugs Sales 2021-2026 (K Units)
Figure 30. APAC Antisense Oligonucleotides (ASOs) Drugs Revenue 2021-2026 ($ millions)
Figure 31. Europe Antisense Oligonucleotides (ASOs) Drugs Sales 2021-2026 (K Units)
Figure 32. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Revenue 2021-2026 ($ millions)
Figure 35. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country in 2026
Figure 36. Americas Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2021-2026)
Figure 37. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Figure 38. Americas Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2021-2026)
Figure 39. United States Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Region in 2026
Figure 44. APAC Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Region (2021-2026)
Figure 45. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Figure 46. APAC Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2021-2026)
Figure 47. China Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. India Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country in 2026
Figure 55. Europe Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share by Country (2021-2026)
Figure 56. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Figure 57. Europe Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2021-2026)
Figure 58. Germany Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. France Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Antisense Oligonucleotides (ASOs) Drugs Sales Market Share by Application (2021-2026)
Figure 66. Egypt Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Antisense Oligonucleotides (ASOs) Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Antisense Oligonucleotides (ASOs) Drugs in 2026
Figure 72. Manufacturing Process Analysis of Antisense Oligonucleotides (ASOs) Drugs
Figure 73. Industry Chain Structure of Antisense Oligonucleotides (ASOs) Drugs
Figure 74. Channels of Distribution
Figure 75. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Forecast by Region (2027-2032)
Figure 76. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Antisense Oligonucleotides (ASOs) Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Antisense Oligonucleotides (ASOs) Drugs Revenue Market Share Forecast by Application (2027-2032)
